Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients.

scientific article

Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/LUPUS-2014-000015
P932PMC publication ID4225738
P698PubMed publication ID25396062
P5875ResearchGate publication ID268282192

P50authorSøren JacobsenQ61093861
Anette Holck DraborgQ87938319
Karen DuusQ117518125
Gunnar HouenQ54867196
Marie WestergaardQ59685399
Janni Lisander LarsenQ59705922
P2093author name stringShila Mortensen
P2860cites workAssociation of Epstein-Barr virus with systemic lupus erythematosus - effect modification by race, age, and cytotoxic T lymphocyte-associate antigen 4 genotypeQ23911107
Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptorsQ24310589
Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in bloodQ24805330
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosusQ29614922
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progressionQ29618956
Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell responseQ30442835
Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE.Q33223891
Understanding the epidemiology and progression of systemic lupus erythematosusQ33621131
Exhausted cytotoxic control of Epstein-Barr virus in human lupusQ34058156
An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosusQ34065673
Clinical and virologic characteristics of chronic active Epstein-Barr virus infectionQ34082763
T cell activation via Leu-23 (CD69)Q69212672
Epstein-Barr viral gene expression in B-lymphocytesQ74788734
Infectious mononucleosis in middle ageQ78024122
Epstein-Barr virus: exploiting the immune systemQ34572150
Increasing incidence of severe Epstein-Barr virus-related infectious mononucleosis: surveillance studyQ34680728
Epstein-Barr virus in autoimmune diseasesQ34887020
Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapiesQ35456519
Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative diseaseQ35787184
Cellular mechanisms governing cross-presentation of exogenous antigensQ35821234
Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophagesQ36327656
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivoQ36350448
Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseasesQ36464560
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.Q36826932
Genetics of clinical expression in SLE.Q37030643
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseasesQ37146126
Systemic lupus erythematosus: clinical presentations.Q37789958
Chronic Epstein-Barr virus infectionQ39509074
Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsilsQ39539494
MHC-I-restricted presentation of HIV-1 virion antigens without viral replicationQ40822849
The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cellQ40843575
Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virusQ41104640
Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.Q41191436
Infectious antibodies in systemic lupus erythematosus patientsQ42992383
Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.Q43726837
Association of Epstein-Barr virus infection with systemic lupus erythematosus in TaiwanQ44005208
An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosusQ44657983
Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients.Q45357292
Polymyositis/dermatomyositis and nasopharyngeal carcinoma: The Epstein–Barr virus connection?Q45372464
Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study.Q45374201
Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus diseaseQ45381481
High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.Q45528509
Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan.Q45586250
Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosusQ45701078
Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosusQ45705505
Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infectionQ45735795
Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposureQ45737398
Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosusQ45797774
EBV and systemic lupus erythematosus: a new perspective.Q51991919
The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1.Q52022569
Systemic lupus erythematosus.Q53495545
Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis.Q55033100
P433issue1
P921main subjectsystemic lupus erythematosusQ1485
Epstein–Barr virusQ6900
lupus erythematosusQ188297
P304page(s)e000015
P577publication date2014-04-01
P1433published inLupus science & medicineQ27725658
P1476titleReduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients
P478volume1

Reverse relations

cites work (P2860)
Q40362391Chronic hepatitis C viral infection among SLE patients: the significance of coexistence
Q40766488Coexistence of systemic lupus erythematosus, tuberous sclerosis and aggressive natural killer-cell leukaemia: coincidence or correlated?
Q90212004EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls
Q35786726Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
Q64235364Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay
Q40473942Humoral markers of active Epstein-Barr virus infection associate with anti-extractable nuclear antigen autoantibodies and plasma galectin-3 binding protein in systemic lupus erythematosus.
Q54263338Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status.
Q36784009Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients
Q35948285Infection and Lupus: Which Causes Which?
Q35591973Isotypes of Epstein-Barr virus antibodies in rheumatoid arthritis: association with rheumatoid factors and citrulline-dependent antibodies
Q59349350Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity
Q41960123Lupus Science and Medicine: the Editors present highlights for the bedside and for the bench in the inaugural issue
Q46461196Strong viral associations with SLE among Filipinos
Q51137468The phenolic fraction of extra virgin olive oil modulates the activation and the inflammatory response of T cells from patients with systemic lupus erythematosus and healthy donors.
Q58554268The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis

Search more.